Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache.

Authors
Category Primary study
JournalNeurology
Year 1989
We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p less than 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.
Epistemonikos ID: 2c5d74024161456f04d85d2dbb1841c0c370e41c
First added on: Jun 26, 2014